Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 Diabetes W. David StrainSu DownAlan Sinclair Review Open access 08 April 2021 Pages: 1227 - 1247
Baseline HbA1c Level Influences the Effect of Periodontal Therapy on Glycemic Control in People with Type 2 Diabetes and Periodontitis: A Systematic Review on Randomized Controlled Trails Ya-fei ChenQi ZhanLong-jiang Li Original Research Open access 22 January 2021 Pages: 1249 - 1278
Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV Matthew J. BudoffTimothy M. E. DavisGiuseppe Derosa Original Research Open access 15 March 2021 Pages: 1279 - 1297
All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK Lise Lotte Nystrup HusemoenLina S. MørchMichael D. Feher Original Research Open access 15 March 2021 Pages: 1299 - 1311
A “Slide Rule” to Adjust Insulin Dose Using Trend Arrows in Adults with Type 1 Diabetes: Test in Silico and in Real Life Daniela BruttomessoFederico BoscariAndrea Facchinetti Original Research Open access 16 March 2021 Pages: 1313 - 1324
Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis Barrie ChubbPalvi GuptaMichelle Orme Original Research Open access 16 March 2021 Pages: 1325 - 1339
A Real-World, Observational Study of the Initiation, Use, and Effectiveness of Basal-Bolus or Premixed Insulin in Japanese People with Type 2 Diabetes Hideaki MiyoshiMike BaxterTakahisa Hirose Original Research Open access 17 March 2021 Pages: 1341 - 1357
Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM Ichiro NakamuraHiroshi MaegawaSatoshi Uno Original Research Open access 17 March 2021 Pages: 1359 - 1378
Role of Structured Education in Reducing Lypodistrophy and its Metabolic Complications in Insulin-Treated People with Type 2 Diabetes: A Randomized Multicenter Case–Control Study Sandro GentileGiuseppina GuarinoAMD-OSDI Study Group on Injection Technique, Nefrocenter Research and Nyx Start-Up Original Research Open access 18 March 2021 Pages: 1379 - 1398
Glycemic Variability and Time in Range During Self-titration of Once Daily Insulin Glargine 300 U/ml Versus Neutral Protamine Hagedorn Insulin in Insulin-naïve Chinese Type 2 Diabetes Patients James LingEmily W. M. PoonElaine Chow Original Research Open access 18 March 2021 Pages: 1399 - 1413
Effects of Sodium Glucose Co-Transporter 2 Inhibitors in Type 1 Diabetes Mellitus on Body Composition and Glucose Variabilities: Single-Arm, Exploratory Trial Yusuke BabaRyoichi IshibashiFumitaka Okajima Original Research Open access 18 March 2021 Pages: 1415 - 1427
Are Chinese Patients with Type 2 Diabetes and a Body Mass Index of 27.5–32.5 kg/m2 Suitable for Metabolic Surgery? A One-Year Post-Surgery Study Ning-Jing ZhangYu-Zhe FuWen-Huan Feng Original Research Open access 19 March 2021 Pages: 1429 - 1444
The “Early Treatment” Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique Giuseppina RussoMatteo MonamiAldo P. Maggioni Original Research Open access 25 March 2021 Pages: 1445 - 1461
Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study Kristina S. BoyeMaureen J. LageJacek Kiljański Original Research Open access 10 April 2021 Pages: 1463 - 1474
Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting Chioma UzoigweYuanjie LiangYurek Paprocki Original Research Open access 10 April 2021 Pages: 1475 - 1489
Glycemic Control and Prevention of Diabetic Complications in Low- and Middle-Income Countries: An Expert Opinion Pablo AschnerGagik GalstyanKamlesh Khunti Original Research Open access 10 April 2021 Pages: 1491 - 1501
Effect of Group Patient Education on Glycemic Control Among People Living with Type 2 Diabetes in Vietnam: A Randomized Controlled Single-Center Trial Ho Thi Kim ThanhTran Manh Tien Original Research Open access 11 April 2021 Pages: 1503 - 1521
The Cost-Effectiveness of Empagliflozin Versus Liraglutide Treatment in People with Type 2 Diabetes and Established Cardiovascular Disease Lars Holger EhlersMark LamotteNiels Ejskjaer Original Research Open access 15 April 2021 Pages: 1523 - 1534
Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: Data from a Real-World Study in Spain Kirsi NorrbackaAntoni Sicras-MainarIrene Romera Original Research Open access 16 April 2021 Pages: 1535 - 1551
Treatment Patterns and Persistence With GLP-1 RA Treatments Among Patients With Type 2 Diabetes in France: A Retrospective Cohort Analysis Sarah Zimner RapuchVictoria DivinoBruno Guerci Original Research Open access 17 April 2021 Pages: 1553 - 1567
Diabetic Ketoacidosis at Emergency Department Presentation During the First Months of the SARS-CoV-2 Pandemic in Israel: A Multicenter Cross-Sectional Study Ron JacobGiora WeiserItai Shavit Brief Report Open access 17 March 2021 Pages: 1569 - 1574
Expert Opinion: A Call for Basal Insulin Titration in Patients with Type 2 Diabetes in Daily Practice: Southeast European Perspective Nicolae HancuAndrej JanezTsvetalina Tankova Practical Approach Open access 15 March 2021 Pages: 1575 - 1589
Correction to: Baseline HbA1c Level Influences the Effect of Periodontal Therapy on Glycemic Control in People with Type 2 Diabetes and Periodontitis: A Systematic Review on Randomized Controlled Trails Ya-fei ChenQi ZhanLong-jiang Li Correction Open access 27 March 2021 Pages: 1591 - 1591